247 related articles for article (PubMed ID: 16207305)
21. PK-PD integration and modeling of marbofloxacin in sheep.
Sidhu PK; Landoni MF; Aliabadi FS; Lees P
Res Vet Sci; 2010 Feb; 88(1):134-41. PubMed ID: 19523661
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
Zhao RK; Cheng G; Tang J; Song J; Peng WX
Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
[TBL] [Abstract][Full Text] [Related]
23. Enrofloxacin-based therapeutic strategy for the prevention of endometritis in susceptible mares.
González C; Moreno L; Fumuso E; García J; Rivulgo M; Confalonieri A; Sparo M; Sánchez Bruni S
J Vet Pharmacol Ther; 2010 Jun; 33(3):287-94. PubMed ID: 20557446
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of marbofloxacin after single intravenous and repeat oral administration to cats.
Albarellos GA; Montoya L; Landoni MF
Vet J; 2005 Sep; 170(2):222-9. PubMed ID: 16129342
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of enrofloxacin following intravenous and intramuscular administration in Angora rabbits.
Elmas M; Uney K; Yazar E; Karabacak A; Traş B
Res Vet Sci; 2007 Apr; 82(2):242-5. PubMed ID: 16930647
[TBL] [Abstract][Full Text] [Related]
26. Serum concentrations and pharmacokinetics of enrofloxacin after intravenous and intragastric administration to mares.
Haines GR; Brown MP; Gronwall RR; Merritt KA
Can J Vet Res; 2000 Jul; 64(3):171-7. PubMed ID: 10935883
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetic variables and tissue residues of enrofloxacin and ciprofloxacin in healthy pigs.
Anadón A; Martínez-Larrañaga MR; Díaz MJ; Fernández-Cruz ML; Martínez MA; Frejo MT; Martínez M; Iturbe J; Tafur M
Am J Vet Res; 1999 Nov; 60(11):1377-82. PubMed ID: 10566812
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics and tissue fluid distribution of cephalexin in the horse after oral and i.v. administration.
Davis JL; Salmon JH; Papich MG
J Vet Pharmacol Ther; 2005 Oct; 28(5):425-31. PubMed ID: 16207304
[TBL] [Abstract][Full Text] [Related]
29. Intrapulmonary pharmacokinetics and pharmacodynamics of high-dose levofloxacin in healthy volunteer subjects.
Conte JE; Golden JA; McIver M; Zurlinden E
Int J Antimicrob Agents; 2006 Aug; 28(2):114-21. PubMed ID: 16837169
[TBL] [Abstract][Full Text] [Related]
30. Population pharmacokinetics of enrofloxacin and its active metabolite ciprofloxacin in ill cows.
Fu LX; Jiang ZG; Ding HZ; Liu YH
J Vet Pharmacol Ther; 2008 Jun; 31(3):240-5. PubMed ID: 18471145
[TBL] [Abstract][Full Text] [Related]
31. Plasma concentrations of enrofloxacin and its active metabolite ciprofloxacin in dogs following single oral administration of enrofloxacin at 7.5, 10, or 20 mg/kg.
Boothe DM; Boeckh A; Boothe HW; Wilkie S; Jones S
Vet Ther; 2002; 3(4):409-19. PubMed ID: 12584678
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of florfenicol and its major metabolite, florfenicol amine, in rabbits.
Park BK; Lim JH; Kim MS; Hwang YH; Yun HI
J Vet Pharmacol Ther; 2007 Feb; 30(1):32-6. PubMed ID: 17217398
[TBL] [Abstract][Full Text] [Related]
33. Ciprofloxacin pharmacokinetics in critically ill patients: a prospective cohort study.
van Zanten AR; Polderman KH; van Geijlswijk IM; van der Meer GY; Schouten MA; Girbes AR
J Crit Care; 2008 Sep; 23(3):422-30. PubMed ID: 18725050
[TBL] [Abstract][Full Text] [Related]
34. Population pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin in chicken based on retrospective data, incorporating first-pass metabolism.
Guo QJ; Huang LL; Fang K; Wang YL; Chen DM; Tao YF; Dai MH; Liu ZL; Peng DP; Yuan ZH
J Vet Pharmacol Ther; 2010 Feb; 33(1):84-94. PubMed ID: 20444030
[TBL] [Abstract][Full Text] [Related]
35. Single-dose intravenous and oral pharmacokinetics of enrofloxacin in goral (Nemorrhaedus goral arnouxianus).
Gandolf AR; Papich MG; Bringardner AB; Atkinson MW
J Zoo Wildl Med; 2006 Jun; 37(2):145-50. PubMed ID: 17312793
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of enrofloxacin after single dose oral and intravenous administration in the African penguin (Spheniscus demersus).
Wack AN; KuKanich B; Bronson E; Denver M
J Zoo Wildl Med; 2012 Jun; 43(2):309-16. PubMed ID: 22779234
[TBL] [Abstract][Full Text] [Related]
37. Comparative pharmacokinetics of marbofloxacin in healthy and Mannheimia haemolytica infected calves.
Ismail M; El-Kattan YA
Res Vet Sci; 2007 Jun; 82(3):398-404. PubMed ID: 17118414
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetic and pharmacodynamic properties of enrofloxacin in southern crested caracaras (Caracara plancus).
Waxman S; Prados AP; de Lucas J; San Andres MI; Sassaroli JC; Orozco M; Argibay H; Rodriguez C
J Avian Med Surg; 2013 Sep; 27(3):180-6. PubMed ID: 24344508
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics and milk penetration of difloxacin after intravenous, subcutaneous and intramuscular administration to lactating goats.
Marín P; Escudero E; Fernández-Varón E; Cárceles CM
J Vet Pharmacol Ther; 2007 Feb; 30(1):74-9. PubMed ID: 17217405
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of ceftazidime after intravenous and intramuscular administration to domestic cats.
Albarellos GA; Ambros LA; Landoni MF
Vet J; 2008 Nov; 178(2):238-43. PubMed ID: 17768077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
